The trading price of Molecular Data Inc. (NASDAQ:MKD) floating lower at last check on Tuesday, Feb 23, closing at $1.83, -9.29% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $1.4700 and $1.7900. The company’s P/E ratio in the trailing 12-month period was 0, while its 5Y monthly beta was 0. In examining the 52-week price action we see that the stock hit a 52-week high of $3.89 and a 52-week low of $0.57. Over the past month, the stock has gained 106.06% in value.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Molecular Data Inc. no upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest MKD has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 50% Buy.
To see how Molecular Data Inc. stock has been performing today in comparison to its peers in the industry, here are the numbers: MKD stock’s performance was -9.29% at last check in today’s session, and -39.4% in the past year, while Spotify Technology S.A. (SPOT) has been trading -8.21% in recent session and positioned +138.12% higher than it was a year ago. Another comparable company Docusign Inc (DOCU) saw its stock trading -2.9% lower in today’s session but was up +174.44% in a year. Furthermore, Aptiv Plc (APTV) showed a decline of -9.29% today while its price kept declining at -39.4% over the past year. Molecular Data Inc. has a P/E ratio of 0, compared to Spotify Technology S.A.’s 0 and Docusign Inc’s 0. Also during today’s trading, the S&P 500 Index has soared -0.93%, while the Dow Jones Industrial also saw a negative seesion, down -0.54% today.
An evaluation of the daily trading volume of Molecular Data Inc. (NASDAQ:MKD) indicates that the 3-month average is 7.19 Million. However, this figure has declined over the past 10 days to an average of 6.64 Million.
Currently, records show that 129.64 Million of the company’s shares remain outstanding. According to Thomson Reuters data, insiders hold 0% of outstanding shares, whereas institutions hold 20.31%. The stats also highlight that short interest as of January 28, 2021, stood at 349.64 Million shares, resulting in a short ratio of 0.03 at that time. From this, we can conclude that short interest is 0.27% of the company’s total outstanding shares. It is noteworthy that short shares in January were up slightly from the previous month’s figure, which was 31.71 Million. However, since the stock’s price has seen +117.86% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.